Many machines are required for pharmaceutical milling processes. Can you reduce that number, streamline operations and improve efficiency?

A change in FTC leadership would likely see a relaxation of antitrust enforcement and an increase in biopharma M&A activity.

One company is determined to improve drug development success rates, and its cell simulation platform is already being used ...

Drugs such as Cobenfy could reshape the antipsychotic market, providing a more nuanced range of patient options.

Lundbeck has completed the acquisition of all outstanding shares of Longboard Pharmaceuticals, to bolster the neuro-rare disease sector.

Olema Oncology and Novartis have signed a clinical trial collaboration and supply agreement for a Phase III trial in metastatic breast cancer.

Turkiye’s pharmaceutical industry has grappled with significant economic challenges such as the frequent upward revision of the pharmaceutical Euro exchange rate.

J&J is seeking approval of TREMFYA for paediatric conditions with the submission of two sBLA to the US Food and Drug Administration.

Novartis has entered a worldwide licensing and partnership agreement with PTC Therapeutics to develop PTC518, a potential oral therapy for Huntington's disease (HD). The PTC518 Huntington's disease ...